Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts    Investorideas.com crypto corner    Play by Play – the latest sports headlines and sports stock news

 


BiodefenseStocks.com - A Leading Global Website for Biodefense Stocks

BioDefenseStocks.com - investing ideas in biodefense stocks

Like Biodefense Stocks? View our Biodefense Stocks Directory


Featured biotech stocks

Aethlon Medical, Inc.

(NasdaqCM:AEMD)


Aethlon Medical (NasdaqCM:AEMD) is a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.

Featured biotech properties

Defense and Security News

Patriot One (TSX.V: $PAT.V) (OTCQX: $PTOTF) @patriot1tech – Makers of PATSCAN CMR covert #Weapondetection System enters into conditional agreement in principle with International #Defence Contractor
TORONTO, ON - August 15, 2018 (Investorideas.com Newswire) Defense stock news alert - Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) ("Patriot One" or the "Company"), makers of the award-winning PATSCAN CMR covert weapon detection system, advises that it has reached an agreement in principle with a major international Defence contractor pursuant to which Patriot One will, subject to certain governmental approvals, receive funding for the further development and integration of its PATSCAN CMR technology.

#Defense #Stock News: Patriot One (TSX.V: $PAT.V) (OTCQX: $PTOTF) @patriot1tech enters into conditional agreement in principle for technology funding with International #Defence Contractor
TORONTO, ON - August 14, 2018 (Investorideas.com Newswire) Patriot One Technologies Inc., (TSX.V: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) ("Patriot One" or the "Company"), makers of the award-winning PATSCAN CMR covert weapon detection system, advises that it has reached an agreement in principle with a major international Defence contractor pursuant to which Patriot One will, subject to certain governmental approvals, receive funding for the further development and integration of its PATSCAN CMR technology.

Cybersecurity Breaches to Result in Over 146 Billion Records Being Stolen by 2023
Hampshire, UK - August 8, 2018 (Investorideas.com Newswire) A new report by Juniper Research found that over 33 billion records will be stolen by cybercriminals in 2023 alone

Good #Trading with #Stock Analyst Guru Richard Lazarow - Support and Resistance Trading Podcast Episode 7 - #Cannabis Stocks and #ETF's, #Cybersecurity
New York, NY and Delta, BC - August 1, 2018 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global news source covering leading sectors issues today’s episode of its educational trading podcast featuring the founder of Stock Analyst Guru, LLC, Richard Lazarow.

Omni-Lite Industries Canada (TSX-V:OML) (OTCQX:OLNCF) Receives New Follow-On Order in Support of Major US #Defense Program
LOS ANGELES - July 30, 2018 (Investorideas.com Newswire) Omni-Lite Industries Canada Inc. (the "Company") (TSX-V:OML) (OTCQX:OLNCF) is pleased to announce today that it received a new follow-on order valued in excess of US$850,000 from one of its long-standing US defense customers in support of a multi-year

Weapons Threat Detection System Undergoes Extensive Testing
July 26, 2018 (Investorideas.com Newswire) An Arizona solar company is a new customer for this rapidly expanding cybersecurity firm.

Cybersecurity Firm Announces New Customer
June 15, 2018 (Investorideas.com Newswire) An Arizona solar company is a new customer for this rapidly expanding cybersecurity firm.

Makers of Concealed #WeaponsDetection System PATSCAN CMR (TSX.V: $PAT.V) (OTCQX: $PTOTF) Patriot One, Announces #ThreatDetection Testing Plans with University of North Dakota
TORONTO, ON - June 29, 2018 (Investorideas.com Newswire) Threat Detection News Alert; Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) makers of the award-winning PATSCAN CMR (Cognitive Microwave Radar) concealed weapons detection system, is pleased to announce plans to develop international Threat Detection Testing at University of North Dakota (UND) main campus in Grand Forks.

#Defense #Stock Breaking News: (TSX.V: $PAT.V) (OTCQX: $PTOTF) Patriot One Finalizes International #ThreatDetection Testing Plans with University of North Dakota @patriot1tech
TORONTO, ON - June 28, 2018 (Investorideas.com Newswire) Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) ("Patriot One" or the "Company"), makers of the award-winning PATSCAN CMR (Cognitive Microwave Radar) concealed weapons detection system, is pleased to announce plans to develop international Threat Detection Testing at University of North Dakota (UND) main campus in Grand Forks.

@patriot1tech - #Security Stock News: Patriot One (TSX.V: $PAT.V) (OTCQX: $PTOTF) Former #CIA's Senior Intelligence Service (SIS) Joins as Strategic Advisor
TORONTO, ON - June 28, 2018 (Investorideas.com Newswire) Security stock news alert- Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) ("Patriot One" or the "Company"), makers of the award-winning PATSCAN CMR (Cognitive Microwave Radar) concealed weapons detection system today announced that Karl Wagner, a former member of CIA's Senior Intelligence Service (SIS), has been hired as an advisor for US Government Relations and Business Development.

Subscribe to Defense and Security News RSS

Submit Articles   Search More Articles

Defense stocks Indices and ETF's

  • PHLX DEFENSE SECTOR INDEX (Philadelphia: ^DFX)
  • S&P Sector Indices Brochure
  • Standard and Poor's 500 Aerospace & Defense Index is a capitalization-weighted index. The index was developed with a base level of 10 for the 1941-43 base period. This is a GICS level 4 sub-industry group. The parent index is SPX. This is a GICS Level 4 Sub-Industry group.
  • The Amex Defense Index (DFI) is an equal dollar weighted Index designed to represent a cross section of widely held, highly capitalized companies involved in providing systems, equipment and services to the United States government and its allies for the purpose of supporting military, defense and intelligence efforts. The component stocks operate in industry segments that include, but are not limited to, military aircraft manufacturing, shipbuilding, ground transportation, aerospace instrumentation and technology, specialized communication and radar systems, ammunition and weapon systems.
  • The iShares Dow Jones U.S. Aerospace & Defense Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Aerospace & Defense Index.
  • The SPADE Defense Index (AMEX: DXS) is a modified market cap-weighted index that was developed to provide a financial benchmark for the performance of companies involved with the defense, homeland security, and space. More than 50 companies currently comprise the index. Information on the Index -- including its methodology, rules, constituents, and performance -- can be found at http://www.spadeindex.com. In October 2005, the first (and currently only) exchange traded fund on defense and homeland security was launched by Powershares. The Powershares Aerospace & Defense Portfolio ETF trades under the symbol 'PPA' and is designed to track the performance of the SPADE. - more info

Biodefense Stocks Directory Preview

Aeolus Pharmaceuticals, Inc ( OTC:AOLS ) is developing a platform of a new class of broad-spectrum, catalytic-antioxidant compounds that protect healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed for oncology indications, where it is used in combination with radiation therapy. It is also being developed, with funding by the US Department of Health and Human Services, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure. Aeolus' strategy is to leverage the substantial investment in toxicology, manufacturing, and preclinical and clinical studies made by US Government agencies in AEOL 10150, including the contract with BARDA valued, with options, at up to $118.4 million, to efficiently develop the compound for use in oncology.

Aethlon Medical (NasdaqCM:AEMD) is a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.

Alexium International Group ( ASX:AJX.AX ) is engaged in developing and licensing its intellectual property, Reactive Surface Treatment (RST) technology. Alexium is focused on developing the RST technology for a range of military and commercial applications. Alexium's Reactive Surface Treatment (RST) is a technology for nanoscopic coatings that combines advanced materials chemistry with a processing step. Alexium's Reactive Surface Treatment (RST) uses cold microwave energy to direct a precursor's polymerization onto a substrate's surface. Its technology is used in textiles, air/fluid filtration, industrial coatings, composite fibers, leather, glass/lens surface treatment, bulk chemicals and thin films. BIODEFENSE: Responding to specific military and first responder needs, Alexium developed the Cleanshell® chemistry to offer a new generation of liquid repellency protection in chemical and biological threat scenarios. Cleanshell® CB is an advanced repellency treatment, optimized for chemical and biological protection. Cleanshell® CB has been optimized to provide excellent water and oil repellency, but has also dramatically increased the repellency of Chemical Warfare Agent (CWA) simulants. Cleanshell® CB offers days of protection versus minutes for conventional fluorocarbon repellency finishes.

American Science and Engineering, Inc ( NasdaqGS: ASEI ) is a leading worldwide supplier of innovative X-ray inspection systems. With over 50 years of experience in developing advanced X-ray security systems, the Company's product line utilizes a combination of technologies, including patented Z Backscatter™ technology, Radioactive Threat Detection (RTD), high energy transmission and dual energy transmission X-ray. These technologies offer superior X-ray threat detection for plastic explosives, plastic weapons, liquid explosives, dirty bombs and nuclear devices. AS&E's complete range of products include cargo inspection systems for port and border security baggage screening systems for facility and aviation security, and personnel and passenger screening systems. AS&E® systems protect high-threat facilities and help combat terrorism, trade fraud, drug smuggling, weapon smuggling, illegal immigration, and people smuggling.

BRUKER Corporation ( NasdaqGS: BRKR ) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial, diagnostics and applied analysis. CBRN (Chemical, biological, radiological, and nuclear defense) : The CBRNE threats facing Armed Forces, Emergency and Security Services across the globe are complex. Simple and reliable solutions are required in order to provide protection and fast, effective response. As the market leader in CBRNE for over 20 years, Bruker understand the threat and needs of those operating against it. Our trusted equipment and software is installed around the world providing unrivalled protection. Our equipment is always easy to use and enables full spectrum Detection, Identification and Monitoring utilising state of the art technology.

Cepheid ( NasdaqGS: CPHD ) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the Company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the Company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. BIOTHREATS : The Cepheid GeneXpert® System makes biothreat agent detection possible in minutes — all from unprepared samples. This easy-to-use, automated and highly accurate real-time PCR instrument combines the ingenuity of more than 30 patents into a sophisticated genetic tool for first responders. A patented, disposable, cartridge test for anthrax is available now, and can be performed on-site — delivering critical answers in critical situations.

Cleveland BioLabs, Inc. ( NasdaqCM:CBLI ) is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need. The company's lead product candidates are Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment and Curaxin CBL0137, our lead oncology product candidate. BIODEFENSE:Entolimod (CBLB502) Biodefense

Dynasil Corporation of America ( NasdaqGM:DYSL ) develops and manufactures detection and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets. Combining world-class technology with expertise in research and materials science, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications, probes for medical imaging and sensors for non-destructive testing.

Electronic Sensor Technology ( OTC:ESNR) develops, manufactures, and sells electronic devices used for vapor analysis. The company offers zNose, an electronic nose designed for various industry applications, which can detect odors and chemical vapors produced by explosives, chemicals, and biological weapons, as well as used for identifying hazardous industrial materials, improvised explosives, and flammable materials. Its product is used in the homeland security, chemical and petrochemical, environmental, life science, and food and beverage industries. The company also provides spare parts, such as columns, saw detectors, and traps; and accessories, including rugged shipping case, battery assemblies, battery chargers, DC/AC inverters, desorbers, heaters, remote samplers, sample injectors, system controllers, user tool kits, and water traps, as well as support and validation services. Electronic Sensor Technology offers its products through online store.

Emergent BioSolutions, Inc. ( NYSE:EBS ) is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. The Company provides the world's only FDA-licensed anthrax vaccine to protect against anthrax disease, BioThrax®.

See the full stock directory here